Medeze Group Public Co., Ltd. engages in the research, development, storage, and testing of stem cells. It operates through the following divisions: Medeze Stemcell, Medeze Nkcell, Medeze Medical & Longevity Institute, Medeze Research & Development, and Medeze Foundation. The Medeze Stemcell division operates a mesenchymal stem cell bank. The Medeze Nkcell division deals with the measurement of natural killer cell activity. The Medeze Medical & Longevity Institute provides medical services. The Medeze Research & Development division focuses on regenerative medicine research. The Medeze Foundation supports medical innovations that can increase longevity, lessen pain, prevent disease and improve recovery rates. The company was founded by Veerapol Khemarangsan, Rangsun Parnpai and Chumrus Sakulpaisal in 2010 and is headquartered in Nakhon Pathom, Thailand.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company